Bevacizumab in the Primary Treatment of Advanced Ovarian, Peritoneal or Fallopian Tube Carcinoma


Bevacizumab in the Primary Treatment of Advanced Ovarian, Peritoneal or Fallopian Tube Carcinoma

CME test Downloadable PDF PowerPoint slides CME Information and Faculty Disclosures
Read Dr Love's original email (from June 30, 2010) Subscribe to Dr Love's email alerts
Transcribed comments from recent interviews with Robert A Burger, MD (6/16/10), Robert L Coleman, MD (6/21/10), Thomas J Herzog, MD (6/21/10), Ursula A Matulonis, MD (6/16/10) and David R Spriggs, MD (6/23/10) about a presentation at ASCO 2010
 

Burger RA et al. Phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal or fallopian tube cancer: A Gynecologic Oncology Group (GOG) study. Proc ASCO 2010;Abstract LBA1.